Catalyst Biosciences
$5.109876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.22 (-4.20%) Today
+$0.08 (+1.59%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell CBIO and other stocks, options, and ETFs commission-free!
About CBIO
Catalyst Biosciences, Inc. Common Stock, also called Catalyst Biosciences, is a clinical-stage biopharmaceutical company. Read More It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA. The listed name for CBIO is Catalyst Biosciences, Inc. Common Stock.
CEO
Employees
34
Headquarters
South San Francisco, California
Founded
2015
Market Cap
110.76M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
499.08K
High Today
$5.34
Low Today
$5.00
Open Price
$5.23
Volume
187.90K
52 Week High
$8.94
52 Week Low
$3.43
Collections
CBIO Earnings
-$1.26
-$0.84
-$0.42
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 5, Pre-Market